Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹885.85
Market cap: ₹49,891 Cr
Revenue (annual): ₹2,124 Cr
Net profit (annual): ₹591.8 Cr
P/E (TTM): 86.6×Sector 47.4×
Promoter holding: 71.42%-3.26% QoQ
FII holding: 2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

6 Apr 2026 18:39 IST BSE

Anthem Biosciences Other Announcement

Anthem Biosciences Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The report, issued by KFin Technologies, confirms regulatory compliance regarding the dematerialisation of securities.

Read the filing ↗